Plain-English translation of NCT04873583 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing whether high-dose steroids can help children recover better from a rare type of stroke caused by inflammation in the brain's blood vessels. Half of the children will receive high-dose steroids along with standard stroke care (including aspirin), while the other half will receive standard care alone. Researchers want to see if the medication helps children regain function faster and prevents future strokes.
Childhood stroke is rare but serious, and most children don't fully recover. Doctors believe inflammation in blood vessels plays a key role in these strokes, and some evidence suggests this treatment might help—but no large clinical trial has tested it yet. This study aims to provide clear answers about whether this medication should become standard treatment.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either high-dose steroids plus standard care, or standard care alone. You'll receive intravenous (IV) steroids followed by oral medication that is gradually reduced over time, or standard care with aspirin. You'll need to come back for follow-up visits and imaging scans to see how well your brain's blood vessels are healing and how well you're recovering from the stroke.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Australia
Austria